Biotech

Gains on two fronts: Same-day test, virus ‘neutralizer’

By GREGORY ZELLER // An ambitious Long Island biotech is reporting exciting progress in a two-front battle against the raging novel coronavirus. Stony Brook-based Applied DNA Sciences on Tuesday announced that it has applied for FDA approval of its Linea COVID-19 diagnostic kit, which detects SARS-CoV-2 – the novel coronavirus that causes the COVID-19 disease – with same-day results. The announcement comes one day after Applied DNA and Italian biopharma Takis Biotech said the first…

Read More

Pending patent a cellulosic score for Applied DNA

By GREGORY ZELLER // A Stony Brook-based biotech on the leading edge of DNA-based product authentication is about to add another U.S. patent to its growing collection. Applied DNA Sciences, which has raced to the front of the Polymerase Chain Reaction-based forensic-traceability field, has received a Notice of Allowance from the U.S. Patent and Trademark Office for its “Methods of Marking Cellulosic Products” – meaning its application to patent the technique has been allowed, and…


‘Linear DNA’ combo shows punch in cancer fight

By GREGORY ZELLER // Mark another impressive victory for LineaRX, this time in a two-front battle against cancer. The Stony Brook-based biotech with innovation in its DNA (literally) has lent its unique DNA-sequencing technology to two vaccine-candidate tests run by Italian R&D company Takis Biotech, which is hot on the trail of new therapeutic cancer vaccines. It might be catching up. On Thursday, LineaRX announced that both vaccines – each produced in “linear DNA” form…


Down is up at Applied DNA, with the good stuff

By GREGORY ZELLER // An aggressive Long Island biotech is getting down, literally, with another global textiles supplier. Stony Brook-based supply-chain security specialist Applied DNA Sciences announced Thursday a new sales and marketing partnership with Navarpluma, a premier supplier of down and feathers to worldwide textiles manufacturers. Financial terms of the deal were not disclosed, but this latest collaboration with an international partner will see Applied DNA’s SigNature DNA molecular-tracking system applied to Navarpluma’s products, which…


Mapping scattered pictures, in the corners of our mind

By GREGORY ZELLER // Straight from the hippocampus (and the horse’s mouth) comes a new research paper in the journal Science, highlighting landmark innovations in human brain mapping. Published Aug. 16 by the peer-reviewed academic journal of the American Association for the Advancement of Science, “Hippocampal Sharp-Wave Ripples Linked to Visual Episodic Recollection in Humans” carries a heavy title but a simple synopsis: real-time mapping of specific brain neurons that fire when humans form visual…


Writing the book, literally, on bioelectronic medicine

By GREGORY ZELLER // The pioneering work of several key researchers has made Long Island a focal point in the emerging science of bioelectronic medicine – their combined knowledge and achievements could fill a book. And it has. Fresh off the Cold Spring Harbor Laboratory Press comes “Bioelectronic Medicine: A Subject Collection From Cold Spring Harbor Perspectives in Medicine,” which belies that awkward academic title with a sharp and exciting focus: groundbreaking progress in bioelectronics,…


With pilot run ending, top marks for LI Bioscience Hub

By GREGORY ZELLER // The Long Island Bioscience Hub is making the grade, according to a report card prepared by independent evaluators. Since launching in 2015, the LIBH – a National Institutes of Health effort uniting Stony Brook University, Brookhaven National Laboratory, Cold Spring Harbor Laboratory and Northwell Health’s Feinstein Institute for Medical Research – has trained hundreds of innovators, helped fund dozens of technology-development projects and assisted the formation of numerous startup companies and…